Monitoring low molecular weight serum proteins in cyclosporine A-treated bone marrow transplant recipients
Duraj, F.F.; Bäckman, L.; Dati, F.; Ringdén, O.
Transplantation Proceedings 22(1): 203-204
1990
ISSN/ISBN: 0041-1345 PMID: 1689888 Document Number: 361776
Document emailed within 1 workday
Related Documents
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315Bursztyn, M.; Zelig, O.; Or, R.; Nagler, A. 1997: Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study Transplantation 63(7): 1034-1036
Mihatsch, M.J.; Thiel, G.; Basler, V.; Ryffel, B.; Landmann, J.; von Overbeck, J.; Zollinger, H.U. 1985: Morphological patterns in cyclosporine-treated renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 101-116
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659
Gibbons, S.; Grevel, J.; Reynolds, K.; Ried, M.; Rutzky, L.P.; Kahan, B.D. 1988: Comparison and correlation of assays for monitoring cyclosporine drug levels in renal transplant recipients Transplantation Proceedings 20(2 Suppl 2: 339-344
Kerman, R.H.; Van Buren, C.T.; Lewis, R.M.; Kahan, B.D. 1988: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients Transplantation Proceedings 20(3 Suppl 3: 264-269
Radovancevic, B.; Birovljev, S.; Frazier, O.H.; Duncan, J.M.; Bennink, W.; Sweeney, M.S.; McAllister, H.A.; Burnett, C.M.; Vega, J.D.; Lonquist, J.L. 1990: Long-term follow-up of cyclosporine-treated cardiac transplant recipients Transplantation Proceedings 22(3 Suppl 1): 21-24
Takahashi, K.; Yagisawa, T.; Teraoka, S.; Tanabe, K.; Ebihara, K.; Fuchinoue, S.; Honda, H.; Toma, T.; Agishi, T.; Ota, K. 1989: Infectious diseases in 450 kidney transplant recipients treated with cyclosporine in a single center Transplantation Proceedings 21(1 Pt 2): 1563-1566
Ovuworie, C.A.; Fox, E.R.; Chow, C.M.; Pascual, M.; Shih, V.E.; Picard, M.H.; Tolkoff-Rubin, N.E. 2001: Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients Transplantation 72(8): 1385-1388
Hale, D.A.; Gottschalk, R.; Fukuzaki, T.; Wood, M.L.; Maki, T.; Monaco, A.P. 1997: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 63(3): 359-364
Grinde, S.; Fagoaga, O.; Thorpe, R.; Wahlstrom, E.; Bailey, L.; Nehlsen-Cannarella, S. 1994: Evaluation of predictors of rejection and infection in cyclosporine-treated solid organ transplant recipients Transplantation Proceedings 26(5): 2738-2740
Francis, D.M.; Walker, R.G.; Jones, C.; Powell, H. 1994: Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone Transplantation Proceedings 26(1): 99-101
Heidecke, C.D.; Nicolaus, C.; Stadler, J.; Florack, G.; Bollschweiler, E.; Hölscher, M. 1987: Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA Transplantation Proceedings 19(1 Part 2): 1734-1736
Hricik, D.E.; Bartucci, M.R.; Moir, E.J.; Mayes, J.T.; Schulak, J.A. 1991: Influence of corticosteroid withdrawal on posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 1007-1008
Diflo, T.; Maki, T.; Monaco, A.P. 1989: Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine Transplantation Proceedings 21(1 Pt 3): 2885-2886
Winston, D.J.; Meyer, D.V.; Gale, R.P.; Young, L.S. 1978: Further experience with infections in bone marrow transplant recipients Transplantation Proceedings 10(1): 247-254
Hauters, P.; de Hemptinne, B.; Carlier, M.; Malaise, J.; Ottobrelli, A.; Delaby, J.; Balducci, G.; Kestens, P.J.; Otte, J.B. 1991: Long-term analysis of glomerular filtration rate and hypertension in adult liver transplant recipients treated with cyclosporine a Transplantation Proceedings 23(1 Part 2): 1458-1459
Remberger, M.; Ringden, O.; Aschan, J.; Ljungman, P.; Lönnqvist, B.; Markling, L. 1994: Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation Proceedings 26(3): 1829-1830
Lee, P.H.; Huang, M.T.; Chung, Y.C.; Hu, R.H.; Tzeng, S.S.; Lee, C.J.; Lee, C.S. 1992: Monitoring of serum neopterin in renal transplant recipients Journal of the Formosan Medical Association 91(12): 1209-1212
Stahl, R.A.; Kanz, L.; Maier, B.; Schollmeyer, P. 1986: Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine a associated side effect Clinical Nephrology 25(5): 245-248